XML 48 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Compensation [Abstract]  
Schedule of Share-Based Compensation Expenses

The following is a summary of share-based compensation expenses reported in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2024 and 2023:

 

   For the Year Ended
December 31,		 
   2024   2023 
Research and Development  $3,227,300   $192,371 
General and Administrative Expenses   381,348    1,543,803 
Total Share-Based Compensation Expense Included in Operating Expenses  $3,608,648   $1,736,174 
Schedule of Fair Value of Options Granted

The following table summarizes the significant assumptions used in determining the fair value of options granted or modified during the years ended December 31, 2024 and 2023:

 

   2024   2023 
Weighted-average grant date fair value  $8.78   $189.60 
Risk-free interest rate   3.62%-4.17%   4.33%
Expected volatility   86.00%-87.00%   110.00%
Expected term (years)   6.41-10.00    3.18 
Expected dividend yield   0.00%   0.00%
Schedule of Stock Option Activities

The following table summarizes the Company’s stock option activities during the year ended December 31, 2024:

 

   Number of
Options		   Weighted
Average
Exercise
Price		   Aggregate
Intrinsic
Value		   Weighted
Average
Remaining
Contractual Life
(Years)		 
Options outstanding, December 31, 2023   632   $318.00   $
            -
    4.53 
Granted   17,005    54.62    
-
    10.00 
Exercised   
-
    
-
    
-
    - 
Forfeited   
-
    
-
    
-
    - 
Expired   
-
    
-
    
-
    - 
Options outstanding, December 31, 2024   17,637   $64.06   $
-
    9.38 
                     
                     
Options vested and exercisable, December 31, 2024   4,437   $116.07   $
-
    8.73 

 

The following table summarizes the Company’s stock option activities during the year ended December 31, 2023:

 

   Number of
Options		   Weighted
Average
Exercise
Price		   Aggregate
Intrinsic
Value		   Weighted
Average
Remaining Contractual Life
(Years)		 
Options outstanding, December 31, 2022   
-
   $
-
   $
           -
    - 
Granted   632    318.00    
-
    5.00 
Exercised   
-
    
-
    
-
    - 
Forfeited   
-
    
-
    
-
    - 
Expired   
-
    
-
    
-
    - 
Options outstanding, December 31, 2023   632   $318.00   $
-
    4.53 
                     
Options vested and exercisable, December 31, 2023   632   $318.00   $
-
    4.53 
Schedule of Restricted Stock Units

The following table summarizes the Company’s RSU activity for the year ended December 31, 2024:

 

    Number of
Units		    Weighted
Average
Grant
Date Fair
Value		 
Unvested balance, December 31, 2023        -     $
-
 
Granted   
-
    
-
 
Vested   
-
    
-
 
Forfeited   
-
    
-
 
Unvested balance, December 31, 2024   
-
   $
-
 

 

The following table summarizes the Company’s RSU activity for the year ended December 31, 2023:

 

   Number of
Units		   Weighted
Average
Grant
Date Fair
Value		 
Unvested balance, December 31, 2022   
-
   $
     -
 
Granted   4,270    52.20 
Vested   (4,270)   52.20 
Forfeited   
-
    
-
 
Unvested balance, December 31, 2023   
-
   $
-